entecavir  - Drug Details
📊 Estimates entecavir  Dialyzability By Different_Modalities

entecavir 

Complete Drug Information

Drug Name
entecavir 
Trade Names
Baraclude
Pregnancy Category
AU: B3
Bioavailability
n/a (≥70)
Routes of Administration
Oral
Protein Binding
13% (in vitro)%
Metabolism
negligible/nil
Elimination
128–149 hours
Excretion
Kidney 62–73%
Formula
C12H15N5O3
Molar Mass
277.284
Melting Point
220 °C
Volume of Distribution
C12H15N5O3

🤰 Pregnancy Category Information

Category: AU: B3

Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus. Animal studies have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.